cancer

FILE - In this Sept. 18, 2014 file photo, produce is displayed for sale at a farmers market in Kalamazoo, Mich. A study released on Wednesday, May 15, 2019 suggests that trimming dietary fat and eating more fruits and vegetables may lower a woman's risk of dying of breast cancer. (Katie Alaimo/Kalamazoo Gazette via AP)
May 15, 2019 - 5:06 pm
For the first time, a large experiment suggests that trimming dietary fat and eating more fruits and vegetables may lower a woman's risk of dying of breast cancer. The results are notable because they come from a rigorous test involving 49,000 women over two decades rather than other studies that...
Read More
FILE - In this Feb. 24, 2019, file photo, containers of Roundup are displayed on a store shelf in San Francisco. A Northern California jury ordered agribusiness giant Monsanto Co. to pay a combined $2.05 billion to a couple who claimed the company's popular weed killer Roundup Ready caused their cancers. The Oakland jury on Monday, May 13, 2019, delivered Monsanto's third such loss in California since August. Alva and Alberta Pilliod claimed they used Roundup for more than 30 years to landscape. They were both diagnosed with non-Hodgkin's lymphoma. Monsanto owner Bayer said it would appeal. (AP Photo/Haven Daley, File)
May 13, 2019 - 10:41 pm
SAN FRANCISCO (AP) — A jury on Monday ordered agribusiness giant Monsanto Co. to pay a combined $2.055 billion to a couple claiming that the company's popular weed killer Roundup Ready caused their cancers. The jury's verdict is the third such courtroom loss for Monsanto in California since August...
Read More
FILE - In this Feb. 24, 2019, file photo, containers of Roundup are displayed on a store shelf in San Francisco. The Environmental Protection Agency is reaffirming that a popular weed killer is safe for users, even as legal claims mount from people who blame the herbicide for their cancer. The EPA’s draft findings Tuesday, April 30, come after two recent multimillion-dollar U.S. court judgments against the herbicide. (AP Photo/Haven Daley, File)
April 30, 2019 - 5:28 pm
WASHINGTON (AP) — The Environmental Protection Agency reaffirmed Tuesday that a popular weed killer is safe for people, as legal claims mount from Americans who blame the herbicide for their cancer. The EPA's draft conclusion Tuesday came in a periodic review of glyphosate, the active ingredient in...
Read More
April 20, 2019 - 2:57 pm
HOUSTON (AP) — A prominent cancer center in Houston has ousted three of five scientists whom federal authorities identified as being involved in Chinese efforts to steal American research. Peter Pisters, the president of MD Anderson Cancer Center, told the Houston Chronicle that the National...
Read More
FILE - In this Friday, Jan. 4, 2018 file photo, a worker adds CBD oil to a drink at a coffee shop in Fort Lauderdale, Fla. Cannabidiol is one of more than 100 compounds found in marijuana. (Jennifer Lett/South Florida Sun-Sentinel via AP)/South Florida Sun-Sentinel via AP)
April 02, 2019 - 10:09 pm
With CBD showing up everywhere, U.S. regulators announced Tuesday they are exploring ways the marijuana extract could be used legally in foods, dietary supplements and cosmetics. The U.S. Food and Drug Administration said it will hold a public hearing May 31 to gather more information on the...
Read More
This March 12, 2019 photo provided by Brigitte Sagasser shows her in San Marcos, Calif. Sagasser, a participant in a federal study for rare cancers, seems to be benefitting from the treatment. Her tumors have been shrinking since starting the treatment a year ago for a rare type of ovarian cancer that defied surgeries, chemotherapy and hormone therapy. (Courtesy Brigitte Sagasser via AP)
April 01, 2019 - 12:34 pm
ATLANTA (AP) — People with rare cancers have been out of luck — not only do most lack good treatments but drug companies also don't pursue them because of small potential sales. Now, a federal study that pools these folks gives them strength in numbers and new options. The first results from this...
Read More
FILE - This Dec. 11, 2006 file photo shows a silicone gel breast implant in Irving, Texas. U.S. health officials are taking another look at the safety of breast implants, the latest review in a decades-long debate. At a two-day meeting that starts Monday, March 25, 2019, a panel of experts for the U.S. Food and Drug Administration will hear from researchers, plastic surgeons and implant makers, as well as from women who believe their ailments were caused by the implants. (AP Photo/Donna McWilliam, File)
March 25, 2019 - 9:30 pm
SILVER SPRING, Md. (AP) — Government medical advisers said Monday it's too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem. The Food and Drug Administration panel didn't recommend any immediate...
Read More
This undated photo provided by the Oregon Health and Science University in March 2019 shows a baby monkey named Grady, at two weeks old, born from an experimental technology that aims to help young boys undergoing cancer treatment preserve their future fertility. Scientists froze testicular tissue from a monkey that had not yet reached puberty, and later thawed it to produce sperm used for Grady’s conception. (OHSU via AP)
March 21, 2019 - 2:08 pm
WASHINGTON (AP) — Scientists are closing in on a way to help young boys undergoing cancer treatment preserve their future fertility — and the proof is the first monkey born from the experimental technology. More and more people are surviving childhood cancer, but nearly 1 in 3 will be left...
Read More
March 19, 2019 - 5:40 pm
SAN FRANCISCO (AP) — A jury in federal court in San Francisco has concluded that Roundup weed killer was a substantial factor in a California man's cancer. The unanimous verdict on Tuesday came in a trial that plaintiffs' attorneys said could help determine the fate of hundreds of similar lawsuits...
Read More
FILE - This Oct. 14, 2015 file photo shows the Food & Drug Administration campus in Silver Spring, Md. On Friday, March 8, 2019, the FDA approved Roche’s Tecentriq, the first cancer immunotherapy for treating an aggressive type of breast cancer. (AP Photo/Andrew Harnik, File)
March 08, 2019 - 6:26 pm
The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Swiss drugmaker Roche's Tecentriq was OK'd Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It's to be given with chemotherapy, the standard...
Read More

Pages